Prof Peter Rothwell speaks to ecancer at the International Aspirin Foundation Scientific Conference 2019 in Rome about the key findings from clinical trials about dosing.

Prof Rothwell explains that there is a lack of modern trials comparing different doses as well as the dosing regimen, but that this is beginning to change.

He also highlights some of the factors to consider when working out the right doses for individual patients. 

Read more on the highlights from the 2019 International Aspirin Foundation Scientific Conference here.